Xianmin Meng

机构：Shanghai Public Health Clinical Center · ORCID：0000-0002-1747-7783

发表论文 52 篇 · 总被引 1040 次 · h-index 16

代表论文

• VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 (2022 · New England Journal of Medicine · 被引 230)
• An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants (2022 · Emerging Microbes & Infections · 被引 69)
• Harnessing Artificial Intelligence to Optimize Long‐Term Maintenance Dosing for Antiretroviral‐Naive Adults with HIV‐1 Infection (2019 · Advanced Therapeutics · 被引 26)
• Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV Infection (2015 · PLoS ONE · 被引 22)
• CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease‐associated pulmonary arterial hypertension (2021 · Journal of Cellular Physiology · 被引 18)
• Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody (2021 · Emerging Microbes & Infections · 被引 13)